Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Obesity01:24

Obesity

1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

245
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
245
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

1.3K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:  
1.3K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

218
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Why do residents choose to specialize in geriatric medicine?

European geriatric medicine·2026
Same author

Response to Boland et al. "Appraisal of the references supporting STOPP/START version 3 criteria".

European geriatric medicine·2026
Same author

[Advocating for geriatrics: a necessary endeavour that requires perseverance].

Revista espanola de geriatria y gerontologia·2026
Same author

Sarcopenia in Diabetes: A proposal on integrating muscle assessment and nutritional intervention in people living with diabetes.

Diabetes research and clinical practice·2026
Same author

Current application and future directions for the sarcopenic obesity Global Leadership Initiative (SOGLI) diagnostic algorithm.

Clinical nutrition (Edinburgh, Scotland)·2026
Same author

Gravity as a key player for the preservation of muscle mass and function in the era of anti-obesity therapies?

Clinical nutrition ESPEN·2026

Related Experiment Video

Updated: Jan 15, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.6K

Sarcopenic Obesity Phenotype Index (SOPi): A Population-Based Study.

Elizabeth Benz1,2, Alexandre Pinel1, Christelle Guillet1

  • 1Human Nutrition Unit, Clermont Auvergne University, Institut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement, Centre de Recherche en Nutrition Humaine, Clermont-Ferrand, France.

Journal of Cachexia, Sarcopenia and Muscle
|October 16, 2025
PubMed
Summary

A new Sarcopenic Obesity Prognostic Index (SOPi) predicts premature death risk. This continuous measure identifies factors associated with sarcopenic obesity (SO) and its progression, aiding in early detection and prevention.

Keywords:
phenotypepopulation‐based studysarcopeniasarcopenic obesitysurvival

More Related Videos

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.1K
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.3K

Related Experiment Videos

Last Updated: Jan 15, 2026

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos
13:35

Segmentation and Linear Measurement for Body Composition Analysis using Slice-O-Matic and Horos

Published on: March 21, 2021

11.6K
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
03:52

The Creation of a Rat Model for Osteosarcopenia via Ovariectomy

Published on: February 21, 2025

1.1K
Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
14:39

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

4.3K

Area of Science:

  • Gerontology
  • Metabolic Health
  • Body Composition Analysis

Background:

  • Sarcopenic obesity (SO) combines high body fat with low muscle mass/function, increasing mortality risk.
  • Current diagnostic methods for SO are binary and limit tracking disease progression.
  • Early detection and monitoring are crucial for managing SO and preventing adverse outcomes.

Purpose of the Study:

  • To develop a continuous Sarcopenic Obesity Prognostic Index (SOPi) integrating muscle function and body composition.
  • To assess the association between SOPi and all-cause mortality.
  • To identify factors related to baseline SOPi and track changes over time.

Main Methods:

  • Utilized data from the Rotterdam Study, including handgrip strength (HGS), appendicular lean mass index (ALM/kg), and body fat percentage (BF%).
  • Calculated SOPi using a sex-specific equation integrating z-scores of BF%, HGS, and ALM/kg.
  • Employed Cox regression and linear mixed-effects models to analyze mortality risk, associated factors, and SOPi changes.

Main Results:

  • Each SD increase in SOPi correlated with a 10% higher risk of premature death (HR=1.10).
  • Thirteen factors, including reduced physical activity, insulin resistance, and inflammation, were linked to high SOPi.
  • Participants with obesity and factors like low physical activity or insulin resistance showed a faster SOPi increase.

Conclusions:

  • SOPi effectively predicts premature death and identifies associated risk factors, especially in individuals at risk for SO.
  • SOPi demonstrates higher values and faster progression in specific phenotypes.
  • The SOPi serves as a valuable prognostic indicator for SO risk assessment and prevention strategies.